Evidence map›Paper›PMID 39109307›Full record

ArticleClinical case reports2024

Echocardiography used for treatment in heart failure accompanied by thyroid storm: Case report and literature review.

Su Wang, Yijing Zhao, Yu Yang, Yuting Pan, Kun Wang

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Iatrogenic Cardiac Arrest During Thyroid Storm.European journal of case reports in internal medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Su WangDepartment of Endocrinology Affiliated Jiangning Hospital of Nanjing Medical University Nanjing China.ORCID https://orcid.org/0000-0002-1645-4213
Yijing ZhaoDepartment of Endocrinology Affiliated Jiangning Hospital of Nanjing Medical University Nanjing China.
Yu YangDepartment of Endocrinology Affiliated Jiangning Hospital of Nanjing Medical University Nanjing China.
Yuting PanDepartment of Endocrinology Affiliated Jiangning Hospital of Nanjing Medical University Nanjing China.
Kun WangDepartment of Endocrinology Affiliated Jiangning Hospital of Nanjing Medical University Nanjing China.ORCID https://orcid.org/0000-0003-1142-0900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: This case highlights the importance of carefully weighing the benefits and risks of beta-adrenergic blockade therapy based on symptoms, echocardiography, and BNP values in thyroid storm patients. Abstract: Thyroid storm is a rare but life-threatening condition in thyrotoxic patients. The keys to successful management of thyroid storm are early diagnosis, immediate anti-thyroid medications, and preventing multiorgan failure. We present a case of thyroid storm, acute decompensated heart failure, and atrial fibrillation with rapid ventricular response. We initiated propranolol to control thyroid storm. Soon after, the patient developed more severe heart failure with decreased ejection fraction (EF). We switched to diltiazem to control tachycardia, but the therapeutic effect was unsatisfactory. Finally, we used an ultra-short-acting beta-adrenergic blockade with strict monitoring of heart rate and echocardiography, and the patient survived. Beta-adrenergic blockades should be used cautiously in thyroid storm, especially patients with severe heart failure. Echocardiography can be used to aid in selection and monitoring of therapeutic drugs and prognostic outcomes in patients with thyroid storm and heart failure.

Indexed as

beta‐adrenergic blockadeBNPechocardiographythyroid storm

Identifiers

PMID39109307
PMCPMC11300817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.